Clinical Trials
9 trialsNCT07017816 2026-04-29
JACOB
Children's National Research Institute
Phase EARLY_PHASE1 Recruiting
NCT04185038 2026-04-13
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Seattle Children's Hospital
Phase 1 Recruiting
NCT06193759 2026-03-10
IMPACT
Children's National Research Institute
Phase 1 Recruiting
NCT06942039 2026-02-27
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
C17 Council
Phase EARLY_PHASE1 Recruiting
NCT07087002 2026-01-27
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Stanford University
Phase 1 Recruiting
NCT04541082 2025-12-18
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Jazz Pharmaceuticals
Phase 1 Recruiting
NCT05259605 2025-12-17
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
European Organisation for Research and Treatment of Cancer - EORTC
Recruiting
NCT02417324 2025-12-04
International HIT-MED Registry (I-HIT-MED)
Universitätsklinikum Hamburg-Eppendorf
Recruiting
NCT03382158 2025-01-30
International PPB/DICER1 Registry
Children's Hospitals and Clinics of Minnesota
Recruiting